Doctors Note Logo

Published on: 9/13/2026

Can berberine cause dangerously low blood sugar or liver damage?

Berberine can lower blood sugar on its own, and hypoglycemia becomes a real risk mainly when it is combined with insulin, sulfonylureas, or other glucose-lowering drugs, while rare cases of elevated liver enzymes and liver injury have been reported, especially at high doses or alongside medications processed by the liver. Warning signs worth taking seriously include shakiness, sweating, confusion, fainting, dark urine, yellowing skin or eyes, and persistent upper right abdominal pain. Dose, duration, existing liver or kidney conditions, and drug interactions all change your personal risk, so see below for the details that matter before you continue or stop taking it. Because these symptoms overlap with many other conditions, a free, instant, private online symptom check can help you sort out whether what you are feeling points to low blood sugar, a liver issue, or something unrelated. It takes about a minute, is doctor-developed, and gives you clear next steps plus questions to bring to a clinician.

Last reviewed for medical accuracy: 09/12/2026

answer background

Explanation

Can Berberine Cause Dangerously Low Blood Sugar or Liver Damage?

Berberine is a natural compound found in several plants, including goldenseal, barberry, and Oregon grape. It’s gained attention for its potential benefits, especially in managing blood sugar and supporting metabolic health. However, as with any supplement, it’s important to understand possible risks—namely hypoglycemia (low blood sugar) and liver damage—and how to use berberine safely.

What Is Berberine and How Does It Work?

Berberine is an alkaloid that has been studied for various health effects:

  • Blood sugar regulation: Activates an enzyme called AMP-activated protein kinase (AMPK), which helps cells take in glucose and improves insulin sensitivity.
  • Cholesterol support: May lower LDL (“bad”) cholesterol and triglycerides.
  • Anti-inflammatory and antimicrobial effects: Shows promise in reducing inflammation and fighting certain infections.

Research into berberine includes randomized controlled trials, systematic reviews, and meta-analyses published in peer-reviewed journals. Always look for high-quality studies when evaluating supplement safety and effectiveness.

Risk of Hypoglycemia (Low Blood Sugar)

How Likely Is Hypoglycemia with Berberine?

Most studies report that berberine safely lowers elevated blood sugar without causing severe hypoglycemia in healthy adults or those with mild to moderate type 2 diabetes. However, certain factors can increase your risk:

  • Combining with other glucose-lowering agents: When taken alongside insulin or sulfonylurea drugs, berberine’s blood-sugar-lowering effects can add up, raising the chance of blood sugar dropping too low.
  • Individual sensitivity: People vary in how they respond to supplements. Some may experience a sharper drop in glucose than others.

Signs of Low Blood Sugar

Be alert to symptoms of hypoglycemia, especially if you’re on diabetic medications:

  • Shaking or jitteriness
  • Sweating
  • Rapid heartbeat
  • Dizziness or lightheadedness
  • Hunger
  • Confusion or difficulty concentrating
  • Irritability

If you experience these signs, check your blood sugar and treat with fast-acting carbohydrates (e.g., glucose tablets, fruit juice) as recommended by your healthcare provider.

Potential for Liver Damage

What Does the Research Say?

Berberine has been studied for liver health, often showing protective effects in animal models of fatty liver disease. Human trials have generally not reported significant liver toxicity at common dosages (900–1,500 mg per day). However, rare cases of elevated liver enzymes have been documented, suggesting mild liver stress in sensitive individuals.

Factors That Increase Liver Risk

  • High dosages: Exceeding recommended amounts may overburden liver metabolism.
  • Underlying liver disease: If you have hepatitis, cirrhosis, or other chronic liver conditions, any additional metabolic load could be problematic.
  • Concurrent hepatotoxic substances: Alcohol, certain medications (e.g., acetaminophen, statins), or other supplements can add stress.

Monitoring Your Liver Health

If you decide to take berberine:

  • Have baseline liver function tests (ALT, AST) before starting.
  • Repeat tests 4–6 weeks after beginning supplementation.
  • Watch for symptoms of liver issues:
    • Unexplained fatigue
    • Dark urine
    • Yellowing of skin or eyes (jaundice)
    • Abdominal pain or swelling

Safe Use Guidelines

To minimize risks and maximize benefits, follow these general recommendations:

  1. Start Low, Go Slow

    • Begin with 500 mg per day, split into two doses.
    • After 2 weeks, if well-tolerated and needed, increase up to 1,500 mg per day.
  2. Take with Meals

    • Berberine’s blood-sugar effects are stronger when taken with food, helping prevent spikes and drops.
  3. Stay Hydrated

    • Proper hydration supports liver detoxification and overall metabolic health.
  4. Avoid High-Risk Combinations

    • If you’re on prescription diabetes medications, discuss adjusting doses with your doctor.
    • Be cautious mixing with other supplements that influence liver enzymes (e.g., kava, high-dose green tea extract).
  5. Monitor Blood Sugar

    • Check fasting and postprandial (after-meal) glucose levels during the first few weeks.
    • Keep a log to share with your healthcare provider.
  6. Monitor Liver Enzymes

    • Repeat liver panels as advised, especially if you have existing liver concerns.

Who Should Be Extra Cautious?

Certain groups should talk to a healthcare professional before trying berberine:

  • People with type 1 diabetes or brittle type 2 diabetes
  • Those on insulin or insulin-secreting medications
  • Individuals with known liver disease or elevated liver enzymes
  • Pregnant or breastfeeding women (insufficient safety data)
  • Children and adolescents

Balancing Benefits and Risks

Many clinical trials report that berberine effectively improves blood sugar, lipid profiles, and even weight management with a low incidence of severe side effects. That said, no supplement is risk-free. By understanding the mechanisms, watching for warning signs, and working with a healthcare provider, you can make an informed decision about whether berberine is right for you.

When to Seek Medical Attention

If you experience any of the following symptoms, seek prompt medical care:

  • Signs of severe hypoglycemia (seizures, loss of consciousness)
  • Symptoms of acute liver injury (jaundice, dark urine, severe abdominal pain)
  • Persistent nausea, vomiting, or diarrhea

For non-urgent concerns, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker. It can help you decide if you need medical attention.

Key Takeaways

  • Berberine is generally safe at recommended dosages (900–1,500 mg/day).
  • Risk of dangerously low blood sugar increases if combined with insulin or certain diabetes drugs.
  • Liver damage is rare but possible—monitor liver enzymes, especially if you have preexisting liver issues.
  • Start with a low dose, take with meals, and watch for symptoms of hypoglycemia or liver stress.
  • Always discuss supplement use with your healthcare provider, particularly if you have chronic health conditions or take prescription medications.

Remember: supplements can interact with medications and individual health conditions. Speak to a doctor before starting berberine, especially if you have diabetes, liver disease, or are taking other medications.

(References)

  • * Song D, Hao J, Fan D. Biological properties and clinical applications of berberine. Front Med. 2020 Oct;14(5):564-582. doi: 10.1007/s11684-019-0724-6. 2020 Apr 25. PMID: 32335802.

  • * Berberine. 2012. PMID: 33242239.

  • * Zhao MM, Lu J, Li S, Wang H, Cao X, Li Q, Shi TT, Matsunaga K, Chen C, Huang H, Izumi T, Yang JK. Berberine is an insulin secretagogue targeting the KCNH6 potassium channel. Nat Commun. 2021 Sep 23;12(1):5616. doi: 10.1038/s41467-021-25952-2. 2021 Sep 23. PMID: 34556670; PMCID: PMC8460738.

  • * Guo J, Chen H, Zhang X, Lou W, Zhang P, Qiu Y, Zhang C, Wang Y, Liu WJ. The Effect of Berberine on Metabolic Profiles in Type 2 Diabetic Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Oxid Med Cell Longev. 2021;2021:2074610. doi: 10.1155/2021/2074610. 2021 Dec 15. PMID: 34956436; PMCID: PMC8696197.

  • * Xie W, Su F, Wang G, Peng Z, Xu Y, Zhang Y, Xu N, Hou K, Hu Z, Chen Y, Chen R. Glucose-lowering effect of berberine on type 2 diabetes: A systematic review and meta-analysis. Front Pharmacol. 2022;13:1015045. doi: 10.3389/fphar.2022.1015045. 2022 Nov 16. PMID: 36467075; PMCID: PMC9709280.

  • * Zhu LR, Li SS, Zheng WQ, Ni WJ, Cai M, Liu HP. Targeted modulation of gut microbiota by traditional Chinese medicine and natural products for liver disease therapy. Front Immunol. 2023;14:1086078. doi: 10.3389/fimmu.2023.1086078. 2023 Feb 2. PMID: 36817459; PMCID: PMC9933143.

  • * Ji L, Ma J, Ma Y, Cheng Z, Gan S, Yuan G, Liu D, Li S, Liu Y, Xue X, Bai J, Wang K, Cai H, Li S, Liu K, Yu M, Liu L. Berberine Ursodeoxycholate for the Treatment of Type 2 Diabetes: A Randomized Clinical Trial. JAMA Netw Open. 2025 Mar 3;8(3):e2462185. doi: 10.1001/jamanetworkopen.2024.62185. 2025 Mar 3. PMID: 40029660; PMCID: PMC11877176.

  • * Cha HR, Kim JS, Ryu JH, Cho HJ. Investigating Neuroprotective Effects of Berberine on Mitochondrial Dysfunction and Autophagy Impairment in Parkinson's Disease. Int J Mol Sci. 2025 Jul 29;26(15). doi: 10.3390/ijms26157342. 2025 Jul 29. PMID: 40806472; PMCID: PMC12346907.

  • * Tao X, Gao Y, Jin Z, Lu S, Li Z, Guo S, Fan Q, Li J, Qiao C, Lei H, Zhang Z, Zhao C, Wu J. Co-administration of berberine and evodiamine: Mitigating evodiamine-induced hepatotoxicity and potentiating colitis treatment. Phytomedicine. 2025 Nov;147:157185. doi: 10.1016/j.phymed.2025.157185. 2025 Aug 20. PMID: 40865345.

  • * Zhang Q, Li N, Ma X, Qiu Y, Li C, Chen Y. Berberine protects against gefitinib-induced liver injury by inhibiting the HMGB1/TLR4/NF-κB pathway. Front Pharmacol. 2025;16:1645634. doi: 10.3389/fphar.2025.1645634. 2025 Aug 26. PMID: 40932871; PMCID: PMC12417729.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.